News

Atzumi, a dihydroergotamine (DHE) nasal powder, was approved by the Food and Drug Administration (FDA) for the acute ...
The U.S. Food and Drug Administration has approved Amneal Pharmaceuticals' self-administered migraine drug, giving way to a ...